Stock Earnings

Question 1

Nurix Therapeutics Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Nurix Therapeutics Inc 的总资产为 $669，净loss为 $-193

Question 2

NRIX 的关键财务比率是什么？

Accepted Answer

Nurix Therapeutics Inc 的流动比率是 4.71，净利 margin 为 -357.4，每股销售为 $0.8。

Question 3

Nurix Therapeutics Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Nurix Therapeutics Inc largest revenue segment is Small Molecule and Cell Therapies, at a revenue of 54,549,000 in the most earnings release.For geography, United States is the primary market for Nurix Therapeutics Inc, at a revenue of 54,549,000.

Question 4

Nurix Therapeutics Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Nurix Therapeutics Inc 的净loss为 $-193

Question 5

Nurix Therapeutics Inc 有负债吗？

Accepted Answer

yes，Nurix Therapeutics Inc 的负债为 142

Question 6

Nurix Therapeutics Inc 的流通股有多少？

Accepted Answer

Nurix Therapeutics Inc 的总流通股为 75.87

Breakdown	TTM	11/30/2024	11/30/2023	11/30/2022	11/30/2021	11/30/2020
Revenue	83	54	76	38	29	17
Revenue Growth (YoY)	48%	-28.99%	100%	31%	71%	-45%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	49	45	42	38	31	16
Research & Development	301	221	189	184	116	66
Operating Expenses	350	267	232	222	147	82
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-244	-193	-143	-180	-117	-63
Income Tax Expense	0	0	--	0	0	-20
Net Income	-244	-193	-143	-180	-117	-43
Net Income Growth	39%	35%	-21%	54%	172%	105%
Shares Outstanding (Diluted)	84.15	67.12	54.33	48.61	42.9	38.86
Shares Change (YoY)	16%	24%	12%	13%	10%	241%
EPS (Diluted)	-2.9	-2.88	-2.64	-3.71	-2.73	-1.11
EPS Growth	19%	9%	-28.99%	36%	146%	-42%
Free Cash Flow	-241	-181	-89	-172	-90	-4
Free Cash Flow Per Share	-2.86	-2.69	-1.63	-3.53	-2.09	-0.1
Gross Margin	--	--	--	--	--	--
Operating Margin	-321.68%	-394.44%	-203.94%	-481.57%	-403.44%	-376.47%
Profit Margin	-293.97%	-357.4%	-188.15%	-473.68%	-403.44%	-252.94%
Free Cash Flow Margin	-290.36%	-335.18%	-117.1%	-452.63%	-310.34%	-23.52%
EBITDA	-264	-204	-148	-178	-115	-62
EBITDA Margin	-318.07%	-377.77%	-194.73%	-468.42%	-396.55%	-364.7%
D&A For EBITDA	3	9	7	5	2	2
EBIT	-267	-213	-155	-183	-117	-64
EBIT Margin	-321.68%	-394.44%	-203.94%	-481.57%	-403.44%	-376.47%
Effective Tax Rate	0%	0%	--	0%	0%	31.74%

Nurix Therapeutics Inc (NRIX) Price

NRIX Stock Price Chart

NRIX Income

Follow-Up Questions